Focus Partners Wealth

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1542153 ST LOUIS, MO

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$58,690,984

-$1,536,078 QoQ

Shares Held

131,435

-1.1% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 77.85385022292753.ToString("F0")% Shared 0.ToString("F0")% None 22.14614977707247.ToString("F0")%

Healthcare · as of Mar 31, 2026

Focus Partners Wealth holds $172,241,737 across 69 Biotechnology names. VRTX ranks #1 (34.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	131,435	$58,690,984
2	CELC	Celcuity Inc.	233,390	$26,639,134
3	REGN	Regeneron Pharmaceuticals, Inc.	16,441	$12,702,974
4	IONS	Ionis Pharmaceuticals Inc	165,544	$12,430,698
5	HALO	Halozyme Therapeutics, Inc.	169,286	$10,940,954
6	INCY	Incyte Corp	116,075	$10,924,979
7	RPRX	Royalty Pharma plc	116,250	$5,576,512
8	EXEL	Exelixis, Inc.	107,776	$4,622,512

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$58,690,984	131,435	-1.1%	Shares	Sole	2026-05-15
2025-12-31	$60,227,062	132,846	-4.6%	Shares	Sole	2026-02-13
2025-09-30	$54,522,162	139,215	-2.7%	Shares	Sole	2025-11-14
2025-06-30	$63,712,126	143,109	-0.1%	Shares	Sole	2025-08-14
2025-03-31	$69,428,648	143,205	+1.5%	Shares	Sole	2025-05-20
2024-12-31	$56,825,802	141,112	+14.8%	Shares	Sole	2025-05-29
2024-09-30	$57,169,959	122,925	+1.1%	Shares	Sole	2024-11-14
2024-06-30	$56,996,820	121,601	+2.6%	Shares	Sole	2024-08-15
2024-03-31	$49,524,570	118,477	+9.6%	Shares	Sole	2024-05-16
2023-12-31	$43,984,809	108,100	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.